The present invention relates to novel amino arylsulfonamide compounds of theformula (I), their derivatives, theirstereoisomers, their pharmaceutically acceptable salts and pharmaceuticallyacceptable compositions containing them: The presentinvention also relates to a process for the preparation of above said novelcompounds, their derivatives, their stereoisomers, theirpharmaceutically acceptable salts and pharmaceutically acceptable compositionscontaining them. The compounds of the inventionare useful in the treatment of various disorders that are related to 5-HT6receptor functions. Specifically, the compounds of thisinvention are also useful in the treatment of various CNS disorders,hematological disorders, eating disorders, obesity, anxiety,depression, diseases associated with pain, respiratory diseases,gastrointestinal, cardiovascular diseases and cancer.
